BARBARA OVERBY: Open Payments
NPI 1356963771 · SOUTH JORDAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 18 payments from 10 companies in 2025. Trend: 2023 $206 · 2024 $535 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $135 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| UCB, Inc. | 1 | $75 |
| ABBVIE INC. | 3 | $62 |
| Janssen Biotech, Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $28 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
| STRATA Skin Sciences, Inc. | 1 | $15 |
| MIMEDX Group, Inc. | 1 | $15 |
| Organon LLC | 1 | $5 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, TREMFYA, COSENTYX, EBGLYSS, Zoryve, LIBTAYO.
Industry payments across UT — which companies pay providers there.
